KSAM

(redirected from FGFR2)
Also found in: Medical, Acronyms.

KSAM

[′kā‚sam]
(computer science)
References in periodicals archive ?
No interaction was found between the 2451 A/G SNP of the FGFR2 gene and the -308 G/A SNP of the TNFA gene.
FGF9 has been shown to interact with only FGFR2 and FGFR3, whereas FGFI and FGF8 can activate all four FGFRs (Table 1; Ornitz et al., 1996).
The analysis showed promising activity in patients with FGFR2 gene fusion-expressing intrahepatic cholangiocarcinoma and also confirmed the safety profile and tolerability of the drug candidate observed in previous clinical studies.
The FGFR2-specific (siBek) or NRP1-specific (siNRP) short interfering RNA, which specifically knock down FGFR2 and Neuropilin 1 gene expression, respectively, as well as negative control siRNA (siNC), which does not lead to the specific degradation of any cellular mRNA, were purchased from Santa Cruz Biotechnology.
Additionally, FGF receptor 2 (FGFR2, GeneID 2263) was downregulated by PPT and DPN.
FGFR2, FGFR3, FGFR1, TWIST1, and EFNB1 genes play a role in the syndromic craniosynostosis presenting with craniofacial abnormalities, including hypertelorism, proptosis, and midfacial hypoplasia.
Furthermore, it has been shown in vivo that astrocytes express FGFR1 mRNA and protein [54-56], as well as FGFR2 mRNA [57].
Terrinoni et al., "DeltaNp63 regulates thymic development through enhanced expression of FgfR2 and Jag2," Proceedings of the National Academy of Sciences of the United States of America, vol.
GWAS for developmental defects of the male reproductive system have also identified candidate genes for hormonal (AR, steroidogenesis, ESR1, and ESR2) and nonhormonal (FGF8, FGFR2, BMP4, and BMP7) pathways underlying hypospadias (Carmichael et al.
For example, the regex for the FGFR2 (fibroblast growth factor receptor 2) variant S267_D273dup would be:
Los subtipos mas importantes, para FGFR1 es FGFR1a, 1b y 1c, para FGFR2, son 2b y 2c y FGFR3, 3b y 3c.
We also report the estimated ln RRs from simple logistic regression for each selected SNP, adjusted for the same set of covariates (age, menarche, menopause, family history, pregnancy, histology, treatment, the FGFR2 GWAS-identified SNP, and deleterious variants in ATM, BRCA1, BRCA2, CHECK2s and offset term) as in our model.